Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Abeona Therapeutics Inc. (ABEO : NSDQ)

• Company Description    Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States. Number of Employees: 226

• Price / Volume Information    Yesterday's Closing Price: $5.44 Daily Weekly Monthly 20 Day Moving Average: 1,187,534 shares Shares Outstanding: 56.99 (millions) Market Capitalization: $310.05 (millions) Beta: 1.35 52 Week High: $7.54 52 Week Low: $4.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.45% -6.26% 12 Week 4.62% -3.29% Year To Date 3.23% -3.70%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6555 Carnegie Avenue 4thFloor - Cleveland,OH 44103 USA ph: 646-813-4701 fax: 214-905-5101 ir@abeonatherapeutics.com http://www.abeonatherapeutics.com

• General Corporate Information    Officers Vishwas Seshadri - President; Chief Executive Officer Michael Amoroso - Chairman of the Board Joseph Vazzano - Chief Financial Officer Leila Alland - Director Mark J. Alvino - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 00289Y206 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 56.99 Most Recent Split Date: 7.00 (0.04:1) Beta: 1.35 Market Capitalization: $310.05 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.23 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.79 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.14 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -25.00% vs. Previous Quarter: 11.76% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 60.89% ROE 03/31/26 - -53.98 12/31/25 - -60.65 09/30/25 - -73.09 ROA 03/31/26 - -38.52 12/31/25 - -40.78 09/30/25 - -44.80 Current Ratio 03/31/26 - 5.89 12/31/25 - 6.93 09/30/25 - 9.74 Quick Ratio 03/31/26 - 5.70 12/31/25 - 6.74 09/30/25 - 9.53 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - 455.56 12/31/25 - 1,224.79 09/30/25 - 20,666.25 Book Value 03/31/26 - 2.54 12/31/25 - 2.94 09/30/25 - 3.34 Inventory Turnover 03/31/26 - 0.89 12/31/25 - 0.47 09/30/25 - 0.26 Debt-to-Equity 03/31/26 - 0.03 12/31/25 - 0.05 09/30/25 - 0.06 Debt-to-Capital 03/31/26 - 3.18 12/31/25 - 4.68 09/30/25 - 5.97

Powered by Zacks Investment Research ©